ARTICLES
& INSIGHT

All the latest articles & insight from our investment writers to inspire your own research and analysis.

Author Index

  • Alpesh Patel OBE
  • Ben Hobson
  • Bruce Packard
  • David Stevenson
  • Elric Langton

Author Index

  • Jason Needham
  • Maynard Paton
  • Michael Taylor
  • Phil Oakley
  • Richard Beddard

Lessons from the Trend (Part 1): Breakouts

All the best trends in the market need to start somewhere. I’m going to show you how to define a trend using two methods and offer some thoughts and reasoning on position management. For my next two articles I will focus on primary trends. If you are unsure what I mean by primary trends please

Read More »

Weekly Commentary: 14/12/20 – Taxes steering behaviour?

After a strong November and start of December the FTSE 100 was largely unchanged this week at 6566. More broadly, the signs of a cyclical recovery are evident: oil price rose through $50 a barrel and copper and other industrial commodities have also been strong. Airbnb IPO’ed with the shares closing on their first day

Read More »

Nichols: More than Vimto

Having prospected for investments in the soft drinks industry, I think Nichols is perhaps the most intriguing of quite an interesting group. It has been enormously profitable and a steady grower, unlike the other candidate, Fever-Tree, which has experienced both extraordinary profit and extraordinary growth. Fever-Tree makes me nervous. Explosive growers rarely keep growing rapidly

Read More »

Weekly Commentary: 07/12/20 – Vaccine inoculating risk tolerance

The best performing FTSE 100 stock last week was Rolls Royce, up 19%. The worst was Unilever down 6.5%, which suggests expectations of a vaccine are inoculating investors against risk. On Nasdaq, the vaccine stock Moderna, was the best performing up 44% in the last 5 days, while Zoom was the second worst performing down

Read More »
DJI DJI 1

Alpesh Patel on US Investing: Stocks set to rally in 2021

“Goldman Sachs says these stocks are set to rally in 2021” It’s a captivating headline, isn’t it? Don’t worry; I’ll tell you which stocks in a moment and whether I agree with Goldman’s. And between Goldman’s history and my own, you might want to bet on me. The US market’s Dow Jones Industrial Average just

Read More »

The Dynamic 35 : The Schroders Asian Total Return Trust

Traditionally most investors tend to regard the division between developed markets (DM) and emerging markets (EM) as a simple divide. We all put more money in the DM but then try and make sure we have some, smaller exposure, to the broad gaggle of national markets which represents the developing world or EM for short.

Read More »

Weekly Commentary: 30/11/20 – The platform bandwagon rolls on

FTSE weakened slightly to 6300 in the second half of last week, but the bounce of former “Covid losers” continued with Rolls Royce, Glencore, Shell and BP all up 8% in the last 5 days. Nasdaq continued to rise to 12152 and Tesla’s value exceeded half a trillion dollars. airbnb IPO Last week airbnb filed

Read More »

The Trader: A look at the pharmaceuticals sector

The pharmaceuticals sector is another popular sector with private investors and retail traders. This is because the volatility is high and traders are often attracted to the blue-sky lottery ticket type stocks. The road for a junior pharmaceutical company is long and hard. First of all, drugs need to go through three phases of testing

Read More »

Finding the soft drinks companies with the most fizz

I know this is going to make me sound like an alcoholic, but I rarely drink soft drinks. When a reader requested an overview of the soft drinks sector, I was not, therefore, particularly enthusiastic. For me, liking the product, or at least seeing its value, is a prerequisite for investment, and, on health grounds,

Read More »

Weekly Commentary: 23/11/20 – Expectations rising

We are beginning to see companies operating in the “real” economy announce raised guidance. Somero (exceeding previous revenue guidance by +7%), but also Headlam (materially ahead), Acesso (comfortably ahead). Saga share price was also up +57% during the week. The FTSE 100 is currently 6378, which is the same level as early March this year.

Read More »

Screening For My Next Long-Term Winner: Manolete Partners

I am always looking for ‘multi-baggers’ — investments that can double, triple, quadruple or more. And here’s some very good news: I have stumbled on a company that can find them for me. Not just the occasional five-bagger or ten-bagger mind, but 20-baggers. It’s incredible stuff, especially as the track record of success extends for

Read More »

Alpesh Patel on US Investing: The Stocks that “Have It All”

Like humans, such perfection doesn’t exist in stocks. Like humans, fish in a big enough pond, and for a while, some get as close as possible. Are they the brands people love the most? Some research by MBLM suggests so. See these images: Wow, great performing companies, and they outgrow their peers. Plus, they are

Read More »